Objective To observe the clinical efficacy of cervus and cucumis polypeptide combined with Duhuo Jisheng Decoction Jiaji pain point injection in the treatment of lumbar intervertebral disc herniation. Methods Totally 68 cases of patients with lumbar intervertebral disc herniation were randomly divided into treatment group (34 cases) and control group (34 cases). Both groups were given Duhuo Jisheng Decoction orally besides basic treatment, and the treatment group received cervus and cucumis polypeptide Jiaji pain point injection additionally. Both groups were in a course of 10 days and treated for two courses. The clinical symptoms, visual analog pain scale (VAS), and Oswestry disability index (ODI) of the two groups were observed and compared among those before treatment, after one and two courses of treatment. Results Compared with the pretreatment of the same group, the VAS and ODI scores were lower after the first and second courses of treatment (P<0.05). After one and two course of treatment, VAS and ODI of the treatment group were lower than the control group (P<0.05, P<0.01). After one course of treatment, the total efficiency of treatment group was 91.2%(31/34), while the control group was 70.6%(24/34);after two courses, the total efficiency were respectively 100%(34/34) and 85.3%(29/34);the treatment group was better than control group during the same period (P<0.05). Conclusion Cervus and cucumis polypeptide combined with Duhuo Jisheng Decoction Jiaji pain point injection has good clinical efficacy in the treatment of lumbar intervertebral disc herniation.%目的：观察鹿瓜多肽夹脊痛点注射配合独活寄生汤加减治疗腰椎间盘突出症的临床疗效。方法将68例腰椎间盘突出症患者随机分为治疗组和对照组各34例,2组均予基础治疗及独活寄生汤加减内服,治疗组另配合鹿瓜多肽夹脊痛点注射,10 d为1个疗程,治疗2个疗程。观察并比较2组患者治疗前及治疗1、2个疗程后临床症状、疼痛视觉模拟评分(VAS)、Oswestry功能障碍指数(ODI)。结果与本组治疗前比较,2组患者治疗1个疗程和2个疗程后VAS、ODI均降低(P＜0.05)。治疗1个疗程、2个疗程后,治疗组VAS、ODI均低于对照组(P＜0.05, P＜0.01)。治疗组和对照组治疗1个疗程后总有效率分别为91.2%(31/34)、70.6%(24/34),2个疗程后分别为100%(34/34)、85.3%(29/34),治疗组优于同期对照组(P＜0.05)。结论鹿瓜多肽夹脊痛点注射配合独活寄生汤加减治疗腰椎间盘突出症临床疗效较好。
展开▼
